Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy

Fig. 3

Effect of empagliflozin on myocardial pathological changes in diabetic mice. A showed freshly harvested mouse hearts under naked eyes. B, C showed the heart weight and the ratio between heart and body weight. D, E were H&E staining of the cross-section of mouse hearts. Data were expressed as the mean ± SEM. **P < 0.01 versus CTRL

Back to article page